Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 3

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 13Other hematologic neoplasm 9Genitourinary 9Breast 9Thoracic 7Lymphoid 5Sarcoma 3Plasma cell 3Myeloid 3Head & Neck 3Gynecologic 2Dermatologic 2Other solid neoplasm 1Classical hematology 1CNS 1

Conditions

Multiple Myeloma 3Neoplasms, Plasma Cell 2Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Fanconi Anemia 1

Interventions

Dexamethasone 478Lenalidomide 297Cyclophosphamide 271Bortezomib 266Melphalan 211Calcium Dobesilate 189fludarabine phosphate 121daratumumab 121Peripheral Blood Stem Cell Transplantation 101fludarabine 99carfilzomib 98Thalidomide 94pomalidomide 92Filgrastim 92Whole-Body Irradiation 88Mycophenolic Acid 88Busulfan 80Tacrolimus 75Granulocyte Colony-Stimulating Factor 72dexamethasone acetate 65ixazomib 62Cyclosporine 59dexamethasone 21-phosphate 56Antilymphocyte Serum 51auricularum 50isatuximab 43Radiotherapy 41Etoposide 40Stem Cell Transplantation 39Methotrexate 33

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Reverse Transcriptase Polymerase Chain Reaction × Plasma cell × Clear all
NCT00900055 2022-07-05

Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma

OHSU Knight Cancer Institute

Completed
213 enrolled
Classical hematologyMyeloidPlasma cell

Fanconi Anemia, Multiple Myeloma, Myeloproliferative Disorders, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases

NCT01155583 2020-11-16

Low-Dose Azacitidine, Lenalidomide, and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma

Case Comprehensive Cancer Center

Phase 1/2 Completed
45 enrolled 20 charts
Plasma cell

Multiple Myeloma

NCT00616720 2011-05-16

Interferon-gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple Myeloma

Mayo Clinic

Phase 2 Completed
15 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡